An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

2020/07/29 by Uğur Şahin, Ugur Sahin, Petra Oehm +40 · 21 citations
Immunology and Microbiology · Medicine · #CAR-T cell therapy research #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses

paper · doi:10.1038/s41586-020-2537-9

crossref issued 2020/07/29 · crossref published 2020/07/29 · crossref published-online 2020/07/29 · openalex publication_date 2020/07/29 · crossref created 2020/07/29 · crossref published-print 2020/09/03 · crossref deposited 2023/05/20 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29 · crossref indexed 2026/07/30

Cited by

• Drug delivery systems for RNA therapeutics
• The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
• Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
• Neoantigens: promising targets for cancer therapy
• Clinical and experimental treatment of advanced melanoma with a focus on immunotherapy
• The Landmark Series: Cancer Vaccines for Solid Tumors
• The mRNA-Based Innovative Strategy: Progress and Challenges
• History and future of RNA medicines
• Boosting CAR-T cell therapy through vaccine synergy
• Cancer vaccines: from an immunology perspective
• Leveraging mRNA technology for antigen based immuno-oncology therapies
• Therapeutic Cancer Vaccines: Mechanisms, Clinical Progress, and Future Directions
• A new strategy for the extrahepatic delivery of lipid-based nanomedicines: a protein corona-mediated selective targeting system based on an ionizable cationic lipid library
• Cancer vaccines as promising immuno-therapeutics: platforms and current progress
• Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer
• CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity
• Surface-engineered robust hybrid lipid nanocapsules: A next-generation nanoplatform for mRNA delivery
• Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization
• mRNA Vaccines in Cancer Immunotherapy: Recent Advances, Clinical Translation, and Future Perspectives
• Melanoma: Pathogenesis and Targeted Therapy
• Opportunity knocking: shared tumor-associated antigen vaccines against global cancer pandemic